Free Republic
Browse · Search
General/Chat
Topics · Post Article

The authors point out that Remdesivir isn’t Gilead’s only antiviral nucleoside analogue. Gilead has also developed GS-441524, another pro-drug that, as its name suggests, the body also converts into GS-441524 triphosphate. As far as drug production goes, GS-441524 is easier to synthesize than remdesivir, requiring only three steps instead of the seven needed for remdesivir.

After reading the linked article I have to ask why Gilead is running to market Remdesivir instead of GS-441524 (a drug both easier to make and more effective than Remdesivir). Beats me. Perhaps because GS-441524 could have fewer years of patent protection remaining?

1 posted on 05/15/2020 2:21:18 AM PDT by House Atreides
[ Post Reply | Private Reply | View Replies ]


To: House Atreides

But the whole point of releasing the virus, at least from Fauci’s and Gates’ point of view, was to sell Remdesivir.

Why start a global plague if you can’t get rich off it? What would be the point?


2 posted on 05/15/2020 4:05:47 AM PDT by thoughtomator (here comes the switch to Hillary)
[ Post Reply | Private Reply | To 1 | View Replies ]

To: House Atreides
The more time that passes, the more weight is granted to my hypothesis that the key to preventing complications in those at-risk is elimination of the virus in the lungs. Such an approach would lower the odds of dying from SARS-CoV-2 infection to a mere fraction of the odds of dying in a vehicle crash for the entire population, not just the young & healthy.

To-wit:

"Remdesivir’s lackluster results in patients with advanced Covid-19 in the NIAID-sponsored trial and the finding that it provided no statistically significant benefit in a clinical trial conducted in China among patients with severe Covid-19 symptoms are likely due to the suboptimal level of active GS-441524 triphosphate in the lungs. Patients with advanced or severe Covid-19 generally have a high viral load in their lungs and would need a high concentration of GS-441524 triphosphate to combat it.

The benefit of using GS-441524 over remdesivir is that GS-441524 can almost certainly be given at much higher doses due to its lower toxicity. This would result in more conversion to the active compound, GS-441524 triphosphate, in the lungs."

Btw:

Wuhan Coronavirus: Propylene Glycol as Possible Therapy for Eradication of RTI and Prevention of Complications [vanity]

But then again, fear is a useful tool, isn't it? /s

3 posted on 05/15/2020 6:05:25 AM PDT by logi_cal869 (-cynicus the "concern troll" a/o 10/03/2018 /!i!! &@$%&*(@ -)
[ Post Reply | Private Reply | To 1 | View Replies ]

Free Republic
Browse · Search
General/Chat
Topics · Post Article


FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson